Condition: Hepatitis B， Chronic · Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Hepatitis B virus (HBV) infection remains one of the most serious health problems worldwide. Patients with chronic HBV infection are at an increased risk for developing hepatic cirrhosis, hepatocellular carcinoma and even death. Although some predictive factors of the outcome of chronic HBV infection were identified, more precisely determine the factors which are associated with the outcome in non-selected patients with chronic HBV infection are still needed. The investigators purpose is to constitute a observational cohort of non-selected Chinese patients to create a database of epidemiological, clinical, biological, virological, immunologic and therapeutic parameters, in order to determine factors associated with the outcome of chronic HBV infection.
This description comes directly from the study's public registry record.
Chao Wu, M.D., Ph.D · 86-25-83105890 · dr.wu@nju.edu.cn
Rui Huang, M.D., Ph.D. · doctor_hr@126.com
Always discuss trial participation with your own doctor first.
| The Third Hospital of Changzhou | Changzhou, Jiangsu, China | Recruiting |
| Huai'an No.4 People's Hospital | Huai'an, Jiangsu, China | Recruiting |
| The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Nanjing, Jiangsu, China | Recruiting |
| Nanjing Jiangbei People's Hospital | Nanjing, Jiangsu, China | Recruiting |
| Suqian People's Hospital | Suqian, Jiangsu, China | Recruiting |
| The Fifth People's Hospital of Suzhou | Suzhou, Jiangsu, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03097952